This poster highlighting an integrated tele-antimicrobial stewardship clinical decision support system implementation was originally presented at IDWeek 2021, held virtually Sept. 29 – Oct. 3, 2021.
Sui Kwong Li, M.D.1,2; Erin K. McCreary, PharmD1,2; Tina Khadem, PharmD1,2; Nancy Zimmerman, RN, BSN2, Sarah Burgdorf, M.D., Ph.D.1,2, Nupur Gupta, DO MPH1,2, Kate Gass, BSN3, Gary S. Fisher, PharmD3, James W. Backstrom, M.D.3, Robin L. Portman, PharmD3; Sara Schwarz, PharmD3; Kimberly Schultz, RPh3, Jenessa Heller, PharmD3, Kris Bearer, RPh3, Jayne Schreckengost, RPh3, Jennifer Prazenica, RPh3, John W. Mellors, M.D.1,2; Rima C. Abdel-Massih, M.D.1,2; J. Ryan Bariola, M.D.1,2
1. Division of Infectious Diseases, UPMC 2. Infectious Disease Connect, Pittsburgh, PA USA 3. 3 Armstrong County Memorial Hospital, Kittanning, PA
Conclusions
- Tele-Antimicrobial Stewardship Program (TASP) in a rural community hospital resulted in a high percentage of accepted stewardship interventions and lower antimicrobial usage.
- Success is dependent on robust educational efforts, establishing strong relationships with local providers, and involvement of key stakeholders.
- Lack of dedicated stewardship time for local pharmacists is a very significant barrier to TASP success.
Objective
- Small hospitals in the US may lack access to infectious diseases (ID) expertise despite similar rates of antimicrobial use and drug-resistant bacteria as larger hospitals.
- A tele-antimicrobial stewardship program (TASP) is a force multiplier, expanding access to specialty care, training, and guidance on appropriate resource utilization.
- Data on the impact of TASPs in community or rural inpatient settings is limited.
Background
- Small hospitals in the US may lack access to infectious diseases (ID) expertise despite similar rates of antimicrobial use and drug-resistant bacteria as larger hospitals.
- A tele-antimicrobial stewardship program (TASP) is a force multiplier, expanding access to specialty care, training, and guidance on appropriate resource utilization.
- Data on the impact of TASPs in community or rural inpatient settings is limited.
Methods
- We established a TASP at a 160-bed hospital in Armstrong County, PA (population 65,000) in September 2020.
- Tele-ID consult services were already being used as of April 2020.
- A non-local ID pharmacist or ID physician with access to the local electronic medical record performed prospective audits and provided feedback with 1 local pharmacist on a 30-minute video conference daily.
- At TASP implementation, all patients receiving intravenous (IV) fluoroquinolones, metronidazole, and azithromycin were reviewed.
- Figure l shows the timeline of TASP implementation.
Results
- From September 2020 to August 2021, 406/519 (78%) stewardship opportunities were accepted (Figure 2).
- Monthly antimicrobial use declined on average from 673 DOT/1000 PD to 638 DOT/1000 PD (Figure 3).
- Daily calls involved ~5 patient reviews though ~20% were cancelled on weekdays due to staffing shortages.
Table 1 TASP Accomplishments
| Patient Care | Guidelines | Microbiology Lab | Policies | Education |
|---|---|---|---|---|
| Available for patient-related questions via email outside of daily TASP call | Empiric antimicrobials for common infections | Enhanced culture results display to providers in electronic health record for improved readability | Indications for use on electronic antibiotic orders | Introduction to stewardship webinar |
| Coaching on conducting through beta-lactam allergy history | COVID-19 | Added clinician comments to culture and laboratory test results | Surgical prophylaxis | Monthly stewardship pearl newsletter |
| Stewardship intervention form | CAP | Updated AST panels and reporting rules to align with current breakpoints | Aminoglycoside dosing | Tocilizumab weinar |
| Patient monitoring form | HAP/VAP | Revised antibiotic reporting rules for Enterococcus spp. isolated in urine cultures | Renal dosing | COVID-19 monthly updates and webinars |
| Prospective audit with feedback M-F | Procalcitonin | Revised cascade reporting rules | MDRO and isolation | |
| IV to PO conversion | Updated local antiiogram | Vancomycin dosing in dialysis |
You might also like…
Infectious Disease Connect and UNM SRMC Release Groundbreaking White Paper on Telemedicine’s Impact on Infectious Disease Care
ID Connect Named “Telehealth Company to Know” by Becker’s Hospital Review
How a Comprehensive Telemedicine Service Model Can Cover an Entire Health Network